GRS Home

The Growth Hormone Research Society


16th GRS Workshop

The GH Research Society held its 16th Workshop on the topic of Safety of GH Treatment in Cancer and Intracranial Tumor Survivors in Children and Adults.

This invitation-only workshop was performed through a web-based platform. We had adapted the schedule of this web-based structure with short online meetings taking place on three different occasions last year (June 9th and 16th, and September 29th). The workshop was organized with the support of the European Society of Endocrinology. Other major endocrine societies had also been invited to nominate delegates to the workshop.

Additionally, representatives from the regulatory agencies, EMA and FDA, attended. A review paper on the topic had been written by members of the program organizing committee, and it was distributed to the delegates prior to the start of the meeting. The format of each workshop had been modified over the years, but the backbone of plenary lectures set the scene followed by breakout group discussions of more specific themes or questions.

The final session was devoted to drafting a statement summarizing the outcome of the workshop that was submitted for publication. GRS had published the results of its previous 15 workshops that had ‘stood the test of time’.

Overview of GRS

The Growth Hormone Research Society (GRS) was founded in 1992 to provide a forum for the study and exchange of ideas on all aspects of growth hormone physiology, and diseases involving abnormalities of the GH axis. With over 400 members from more than 30 countries, the society represents a unique international body composed of clinicians, scientists, educators, and students.  These individuals are committed to the advancement and dissemination of research and education on a milieu of medical and biological topics related to GH. Among these are GH deficiency, GH excess, and the use of GH and related products in the treatment of these diseases. The society holds biannual meetings in conjunction with its sister society, the IGF research society. The official publication of GRS is Pituitary (The Official Journal of the Pituitary Society and Growth Hormone Research Society).


Mission of GRS

The mission of the GRS is to promote scientific research and clinical advancement in the fields of growth hormone (GH) and insulin-like growth factors (IGFs).

This GRS consensus academic society conducts this mission as an independent, non-profit society that facilitates and evaluates advances in the physiology, pathology, diagnostics, therapeutics, and surveillance of GH/IGF-related disorders.

The GRS fosters collaborations between basic scientists, clinicians (paediatric and adult) and clinical investigators from both the public and private sectors to promote research.

The GRS conveys knowledge through the Society’s journal, scientific meetings and workshops.

Who should join

The GRS engages basic scientists, clinicians (paediatric and adult) and clinical investigators from both the public and the private sectors, to promote collaborative research and convey knowledge through our society’s journal, scientific meetings and workshops. Additionally, postdoctoral fellows, medical students, and graduate students are encouraged to join.





Consensus Statements


Honorary Members


hGH Indications



IGF Society